Protective mechanism in NPC1 – the role of oxLDL
DOI:
https://doi.org/10.26481/marble.2015.v6.373Abstract
The Niemann Pick disease type C1 (NPC1) is a lysosomal storage disorder caused by a mutation in the NPC1 gene. The mutation disrupts the normal cholesterol traficking and induces cholesterol accumulation in cells of the liver and the brain. Till now, no therapy exists for NPC1 patients. But recently, pneumococci immunization has shown to reduce inflammation in Non-alcoholic steatohepatitis (NASH), another lipid storage disorder. Therefore, pneumococci immunization was also tested on NPC1mut mice. The results indicate an improved pathology in the NPC1 mice after the immunizationReferences
Bieghs, V., van Gorp, P. J., Walenbergh, S. M., Gijbels, M. J., Verheyen, F., Buurman, W. A., Shiri-Sverdlov, R.(2012). Specific immunization strategies against oxidized low-density lipoprotein: a novel way to reduce nonalcoholic steatohepatitis in mice. Hepatology, 56(3), 894-903. doi: 10.1002/hep.25660
Bieghs, V., Walenbergh, S. M., Hendrikx, T., van Gorp, P. J., Verheyen, F., Olde Damink, S. W., Shiri-Sverdlov, R.(2013). Trapping of oxidized LDL in lysosomes of Kupffer cells is a trigger for hepatic inflammation. Liver Int, 33(7), 1056-1061. doi: 10.1111/liv.12170
Binder, C. J., Chang, M.-K., Shaw, P. X., Miller, Y. I., Hartvigsen, K., Dewan, A., & Witztum, J. L. (2002). Innate and acquired immunity in atherogenesis. Nature medicine, 8(11), 1218-1226.
Chang, T.-Y., Reid, P. C., Sugii, S., Ohgami, N., Cruz, J. C., & Chang, C. C. (2005). Niemann-Pick type C disease and intracellular cholesterol trafficking. Journal of Biological Chemistry, 280(22), 20917-20920.
Patterson, M. C., Hendriksz, C. J., Walterfang, M., Sedel, F., Vanier, M. T., & Wijburg, F. (2012). Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update. Mol Genet Metab, 106(3), 330-344. doi: 10.1016/j.ymgme.2012.03.012
Praggastis, M., Tortelli, B., Zhang, J., Fujiwara, H., Sidhu, R., Chacko, A., Ory, D. S. (2015). A Murine NiemannPick C1 I1061T Knock-In Model Recapitulates the Pathological Features of the Most Prevalent Human Disease Allele. J Neurosci, 35(21), 8091-8106. doi: 10.1523/jneurosci.4173-14.2015
Smith, D., Wallom, K. L., Williams, I. M., Jeyakumar, M., & Platt, F. M. (2009). Beneficial effects of antiinflammatory therapy in a mouse model of Niemann-Pick disease type C1. Neurobiol Dis, 36(2), 242-251. doi: 10.1016/j.nbd.2009.07.010
Uronen, R. L., Lundmark, P., Orho-Melander, M., Jauhiainen, M., Larsson, K., Siegbahn, A., Ikonen, E. (2010). Niemann-Pick C1 modulates hepatic triglyceride metabolism and its genetic variation contributes to serum triglyceride levels. Arterioscler Thromb Vasc Biol, 30(8), 1614-1620. doi: 10.1161/atvbaha.110.207191
Vanier, M. T. (2015). Complex lipid trafficking in Niemann-Pick disease type C. J Inherit Metab Dis, 38(1), 187-199. doi: 10.1007/s10545-014-9794-4
